Inflation Devices Market Report

Global Inflation Devices Market Size

The global inflation devices market is projected to grow from USD 697.59 million in 2024 to USD 1100.88 million by 2033, at a CAGR of 5.2%.

MARKET DRIVERS

Inflation devices are used in the medical field to increase or decrease pressure in balloons that are involved in angioplasty treatment or blood pressure monitoring. The rising cases of cardiovascular diseases such as heart failure and heart attacks around the world are the primary factors driving the global inflation devices market. Also, the spike in the geriatric population that requires angioplasty procedures to treat heart problems is another factor driving this business growth. The lack of work-life balance coupled with rising hypertension is promoting the use of blood pressure monitoring devices that use inflation devices. In addition, the increasing awareness about cardiovascular health and preference for minimally invasive procedures also created a positive outlook for the inflation devices market. The surge in interest among private and public sectors to develop innovative healthcare solutions is supposed to produce more accurate and affordable options, increasing demand in the inflation devices business. Besides, the growing healthcare expenses and adoption of novel medical techniques to ensure more safety, convenience, and comfort to patients are contributing to the adoption of inflation devices. Similarly, the trend of medical tourism allowed patients to travel to different parts of the world for affordable and effective treatments, creating a promising future for the inflation devices market. Moreover, the supportive government initiatives and rising partnerships within the healthcare and research institutions are likely to create numerous opportunities for the inflation devices business in the following years.

MARKET RESTRAINTS

The major hurdle to the global inflation devices market is the high cost associated with the production of high-quality devices. The stringent regulations and delayed approvals for medical devices are also acting as a limitation for several new players to enter the inflation devices business. In addition, the lack of proper understanding about these devices among the patients along with the unavailability of proper insurance support in several emerging nations is also leading to a negative impact on the market. Also, the limited reimbursement conditions and the economic uncertainties are pulling some manufacturers to invest more in advanced products like inflation devices. Besides, the cases of blood loss or infections during the procedures are slowing down the adoption of inflation devices in several healthcare applications. Furthermore, the missing standardization to integrate or combine with existing medical practices, shortage of experienced healthcare professionals, challenges around data privacy with the integration of digital solutions, and changing preferences of patients for telehealth are anticipated to constrain the inflation devices market over the foreseeable period.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Display Type Insights

The analog segment accounted for the majority share of the global market as it is the most preferred type of device during angioplasty procedures. The increasing prevalence of heart failures and ailments along with the global trend of the elderly population is supporting the growth of this segment. The high accuracy and affordable costs compared to its counterpart are fuelling the adoption of the analog display type.

By Application Insights

The interventional cardiology segment dominated with the highest share in the global inflation devices market due to the augmented cases of cardiovascular diseases among patients. The surge in lifestyle diseases like obesity and stress directly affects the functionality of the heart and leads to increased cases of angioplasty procedures. Similarly, peripheral vascular treatments are likely to increase in the coming years. The overall developments in the healthcare infrastructure and consumer preference for minimally invasive processes are expected to boost the adoption of inflation devices in the forecast period.

By Capacity Insights

The 60ml segment is anticipated to expand at a significant rate in the global inflation devices market over the predicted period. The need for large-capacity balloons to be used in procedures like gastroenterology, pulmonology, and others, is supporting the growth in this segment.

By End-Use Insights

The hospitals and clinics segment registered the prominent portion of the global inflation devices market due to the availability of multiple procedures and certified professionals in one place. The widespread prominence of procedures like angioplasty, peripheral vascular, and interventional cardiology, the availability of advanced infrastructure, and the growth of target diseases are propelling the hospital segment in the international marketplace.

REGIONAL ANALYSIS

North America recorded the highest share of the global inflation devices market and is likely to grow at a steady rate in the coming years. The USA and Canada are the leading nations in this area. The advanced medical sector and the increase in the number of patients with cardiovascular problems are fuelling the business growth in this area. The USA accounts for the dominant share in North America due to the surge in demand for advanced and minimally invasive treatments among all demographics. Moreover, the booming investments in novel healthcare applications and research and development activities are likely to promote the use of inflation devices more in this area.

Asia Pacific is expected to register the highest growth rate in this market over the predicted period due to the advances in healthcare technologies and growing awareness about the benefits of inflation devices among consumers. In addition, the affordability of various diagnostic procedures in Asian countries compared to Western nations is encouraging more patients to avail themselves of these services. Moreover, the expanding population and improving disposable income conditions are anticipated to drive market growth in the APAC nations. China and India are leading nations in the Asia Pacific region.

Europe is also a significant market for inflation devices owing to the increasing elderly population and rising cases of cardiovascular problems. The recent surge in treatments like angioplasty and strategic funding towards research and development activities also promotes the inflation devices market in this locale. Some of the prominent nations in the European inflation devices market are the United Kingdom, Germany, Spain, Italy, and France.

Latin America registered a smaller portion of the global inflation devices market. However, the increasing demand for advanced treatments, the rise in medical investments, and improvements in disposable income in nations like Brazil and Mexico are likely to create lucrative opportunities in this area.

The Middle East and Africa are also smaller players in the inflation devices market. Recently, nations in this region started investing in healthcare infrastructure and advanced therapeutics, which can create positive opportunities for this regional market in the future.

KEY MARKET PLAYERS

Medtronic PLC, Boston Scientific Corporation, Cardinal Health, Atrion Corporation, Teleflex Incorporated, CONMED Corporation, Merit Medical Systems, Acclarent Inc., Becton, Dickinson and Company, Terumo Medical Corporation, Olympus Corporation, US Endovascular, Johnson & Johnson Services, B. Braun SE, Abbott, Smiths Group, Stryker Corporation, and TZ Medical Inc.

RECENT MARKET DEVELOPMENTS

• In June 2023, MDev BV’s division SYNDEO Medical introduced its new inflation device, SATURN. This device from SYNDEO aims to offer a complete solution to healthcare providers by integrating with the company’s SYNDEOPack platform, which can support advanced care.
• In 2022, Merit Medical introduced its inflation device basic ALPHA to support angioplasty treatments. Expanding its existing product line, Merit Medical streamlines the angioplasty procedure with this new inflation device that supports fast inflation with less exertion and single-handed preparation.

MARKET SEGMENTATION

This research report on the global inflation devices market is segmented and sub-segmented based on display type, application, capacity, end-use and region.

By Display Type

• Analog
• Digital

By Application

• Interventional Cardiology
• Interventional Radiology
• Gastroenterology Procedures
• Peripheral Vascular Treatments
• Urology Procedures
• Others

By Capacity

• 20ml
• 30ml
• 60ml

By End-Use

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa